APGE
Apogee Therapeutics, Inc. Common Stock
stock NASDAQ

Sure, the AML TAM is over 5-6B a year in peak sales. Slap a 4x multiple on that and youre at 20B. that gives 0 credit to the post transplant market or expansion for GPS solid tumors, or the SLS009 platform. That is purely AML frontline + CR1 + CR2
What i meant in my post by market mechanics is that buyouts are typically some control premium \* market price. Look at APGE. BP paid a 50% control premium - stock was at 95, buyout was for \~133.
This means that if we're trading at 60 after the unblinding, the buyout floor is around 90 (i argue 100 since there will almost definitely be multiple bidders).
GPS TAM in and of itself easily validates this, but market mechanics will force the acquirer's hand.

Sure, the AML TAM is over 5-6B a year in peak sales. Slap a 4x multiple on that and youre at 20B. that gives 0 credit to the post transplant market or expansion for GPS solid tumors, or the SLS009 platform. That is purely AML frontline + CR1 + CR2
What i meant in my post by market mechanics is that buyouts are typically some control premium \* market price. Look at APGE. BP paid a 50% control premium - stock was at 95, buyout was for \~133.
This means that if we're trading at 60 after the unblinding, the buyout floor is around 90 (i argue 100 since there will almost definitely be multiple bidders).
GPS TAM in and of itself easily validates this, but market mechanics will force the acquirer's hand.